PUMA BIOTECHNOLOGY, INC. (PBYI)

Pharmaceutical Preparations · Healthcare · $621M

overvalued
Intrinsic Value (Consensus)
$8.61
Current Price
$12.20
Margin of Safety
-29.4%
29.4% Above Intrinsic Value
Value: $9
Price: $12

Valuation Model Estimates

Current Price: $12.20
DCF (Discounted Cash Flow)
$10.40
Graham Number
$5.93
Earnings Power Value
$5.92
Relative Value (P/E)
$12.20
Dividend Discount Model
Not applicable
Consensus Value
$8.61

Model Assumptions

Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Key Financials

EPS (TTM)
$0.61
EPS (Forward)
$0.62
Book Value
$2.56
P/E Ratio
20.0
Forward P/E
19.6
PEG Ratio
ROE
23.9%
Debt/Equity
17%
Revenue Growth
-0.9%
Earnings Growth
2.0%
Dividend Yield
N/A
Beta
1.00

Data last updated: 2026-06-12

Source: Yahoo Finance